Related references
Note: Only part of the references are listed.High-calorie diet inflates steatogenic effects of valproic acid in mice
Chandrasekaran Sathiya Priya et al.
TOXICOLOGY MECHANISMS AND METHODS (2016)
Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades
Zhichao Liu et al.
SCIENTIFIC REPORTS (2016)
High-calorie diet inflates steatogenic effects of valproic acid in mice
Chandrasekaran Sathiya Priya et al.
TOXICOLOGY MECHANISMS AND METHODS (2016)
Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro
Wim F. P. M. Van den Hof et al.
TOXICOLOGY IN VITRO (2015)
Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury
A. D. B. Vliegenthart et al.
SCIENTIFIC REPORTS (2015)
High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins
Laia Tolosa et al.
ARCHIVES OF TOXICOLOGY (2015)
A simple transcriptomic signature able to predict drug-induced hepatic steatosis
Marta Benet et al.
ARCHIVES OF TOXICOLOGY (2014)
The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles
Yunfei Bai et al.
GENE (2014)
Rosiglitazone and Fenofibrate Exacerbate Liver Steatosis in a Mouse Model of Obesity and Hyperlipidemia. A Transcriptomic and Metabolomic Study
Anna Rull et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Uridine Prevents Fenofibrate-Induced Fatty Liver
Thuc T. Le et al.
PLOS ONE (2014)
Peroxisome Proliferator-Activated Receptor α Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect
Fang Yan et al.
PLOS ONE (2014)
Drug-Induced Hepatic Steatosis
David E. Amacher et al.
SEMINARS IN LIVER DISEASE (2014)
Development of Blood Biomarkers for Drug-Induced Liver Injury: An Evaluation of Their Potential for Risk Assessment and Diagnostics
David E. Amacher et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice
Mingming Gao et al.
PLOS ONE (2013)
PolyA RT-PCR-based quantification of microRNA by using universal TaqMan probe
Xin Luo et al.
BIOTECHNOLOGY LETTERS (2012)
Drug-induced Liver Steatosis and Phospholipidosis: Cell-Based Assays for Early Screening of Drug Candidates
M. Teresa Donato et al.
CURRENT DRUG METABOLISM (2012)
Circulating MicroRNAs as Potential Markers of Human Drug-Induced Liver Injury
Philip J. Starkey Lewis et al.
HEPATOLOGY (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Fenofibrate Simultaneously Induces Hepatic Fatty Acid Oxidation, Synthesis, and Elongation in Mice
Maaike H. Oosterveer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Histological patterns in drug-induced liver disease
R. Ramachandran et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Kai Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Nonalcoholic fatty liver disease and mitochondrial dysfunction
Yongzhong Wei et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
A human hepatocellular in vitro model to investigate steatosis
Maria Jose Gomez-Lechon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening
P. J. O'Brien et al.
ARCHIVES OF TOXICOLOGY (2006)
Fenofibrate, a peroxisome proliferator-activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver
Yuichi Harano et al.
LIVER INTERNATIONAL (2006)
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
R Shiri-Sverdlov et al.
JOURNAL OF HEPATOLOGY (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
A web-based tool for principal component and significance analysis of microarray data
AA Sharov et al.
BIOINFORMATICS (2005)
Drug-induced acute liver failure
D Larrey et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Do preclinical testing strategies help predict human hepatotoxic potentials?
TS Peters
TOXICOLOGIC PATHOLOGY (2005)
Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets
CL Andersen et al.
CANCER RESEARCH (2004)
Share Paper
